ID BL AC CVCL_U802 SY BLmel; BL mel DR cancercelllines; CVCL_U802 DR Cosmic; 888987 DR Cosmic; 897737 DR Cosmic; 928724 DR GEO; GSM170823 DR Wikidata; Q54797091 RX PubMed=1697409; RX PubMed=9331097; RX PubMed=9354451; RX PubMed=15048078; RX PubMed=15688405; RX PubMed=17516929; RX PubMed=19383913; RX PubMed=22383533; RX PubMed=23039341; CC Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15048078; PubMed=22383533). CC Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu88Lys (c.262G>A); ClinVar=VCV000821566; Zygosity=Unspecified (PubMed=9354451). CC Omics: Transcriptomics; Microarray. DI NCIt; C3224; Melanoma OX NCBI_TaxID=9606; ! Homo sapiens (Human) SX Sex unspecified AG Age unspecified CA Cancer cell line DT Created: 16-04-14; Last updated: 14-08-25; Version: 17 // RX PubMed=22383533; DOI=10.1158/1535-7163.MCT-11-0676; RA Dutton-Regester, Ken RA Irwin, Darryl RA Hunt, Priscilla RA Aoude, Lauren G. RA Tembe, Varsha RA Pupo, Gulietta M. RA Lanagan, Cathy RA Carter, Candace D. RA O'Connor, Linda RA O'Rourke, Michael RA Scolyer, Richard Anthony RA Mann, Graham J. RA Schmidt, Christopher W. RA Herington, Adrian RA Hayward, Nicholas K. RT "A high-throughput panel for identifying clinically relevant mutation RT profiles in melanoma."; RL Mol. Cancer Ther. 11:888-897(2012). // RX PubMed=15048078; DOI=10.1038/sj.onc.1207563; RA Pavey, Sandra RA Johansson, Peter RA Packer, Leisl RA Taylor, Jennifer RA Stark, Mitchell S. RA Pollock, Pamela M. RA Walker, Graeme J. RA Boyle, Glen M. RA Harper, Ursula RA Cozzi, Sarah-Jane RA Hansen, Katherine RA Yudt, Laura RA Schmidt, Chris RA Hersey, Peter RA Ellem, Kay Adrian Oswald RA O'Rourke, Michael G.E. RA Parsons, Peter G. RA Meltzer, Paul S. RA Ringner, Markus RA Hayward, Nicholas K. RT "Microarray expression profiling in melanoma reveals a BRAF mutation RT signature."; RL Oncogene 23:4060-4067(2004). // RX PubMed=15688405; DOI=10.1002/ijc.20873; RA Eskandarpour, Malihe RA Kiaii, Shahryar RA Zhu, Chao-Yong RA Castro, Juan RA Sakko, Andrew J. RA Hansson, Johan RT "Suppression of oncogenic NRAS by RNA interference induces apoptosis RT of human melanoma cells."; RL Int. J. Cancer 115:65-73(2005). // RX PubMed=9354451; RA Castellano, Marina RA Pollock, Pamela M. RA Walters, Marilyn K. RA Sparrow, Louise E. RA Down, Louise M. RA Gabrielli, Brian G. RA Parsons, Peter G. RA Hayward, Nicholas K. RT "CDKN2A/p16 is inactivated in most melanoma cell lines."; RL Cancer Res. 57:4868-4875(1997). // RX PubMed=19383913; DOI=10.1158/0008-5472.CAN-08-3746; RA Cedervall, Jessica RA Jamil, Seema RA Prasmickaite, Lina RA Cheng, Yen-Fu RA Eskandarpour, Malihe RA Hansson, Johan RA Maelandsmo, Gunhild Mari RA Ringborg, Ulrik RA Gulyas, Miklos RA Zhen, He-Suo RA Kanter, Lena RA Ahrlund-Richter, Lars RT "Species-specific in vivo engraftment of the human BL melanoma cell RT line results in an invasive dedifferentiated phenotype not present in RT xenografts."; RL Cancer Res. 69:3746-3754(2009). // RX PubMed=9331097; RA Salazar-Onfray, Flavio RA Nakazawa, Tsutomu RA Chhajlani, Vijay RA Petersson, Max RA Karre, Klas RA Masucci, Giuseppe RA Celis, Esteban RA Sette, Alessandro RA Southwood, Scott RA Appella, Ettore RA Kiessling, Rolf RT "Synthetic peptides derived from the melanocyte-stimulating hormone RT receptor MC1R can stimulate HLA-A2-restricted cytotoxic T lymphocytes RT that recognize naturally processed peptides on human melanoma RT cells."; RL Cancer Res. 57:4348-4355(1997). // RX PubMed=17516929; DOI=10.1111/j.1600-0749.2007.00375.x; RA Johansson, Peter RA Pavey, Sandra RA Hayward, Nicholas K. RT "Confirmation of a BRAF mutation-associated gene expression signature RT in melanoma."; RL Pigment Cell Res. 20:216-221(2007). // RX PubMed=1697409; RA Chenevix-Trench, Georgia RA Martin, Nicholas Gordon RA Ellem, Kay Adrian Oswald RT "Gene expression in melanoma cell lines and cultured melanocytes: RT correlation between levels of c-src-1, c-myc and p53."; RL Oncogene 5:1187-1193(1990). // RX PubMed=23039341; DOI=10.1186/1476-4598-11-75; PMCID=PMC3554420; RA Byron, Sara A. RA Loch, David C. RA Wellens, Candice L. RA Wortmann, Andreas RA Wu, Jia-Yi RA Wang, John RA Nomoto, Kenichi RA Pollock, Pamela M. RT "Sensitivity to the MEK inhibitor E6201 in melanoma cells is RT associated with mutant BRAF and wildtype PTEN status."; RL Mol. Cancer 11:75.1-75.15(2012). //